N. Bellamy

1.5k total citations
42 papers, 1.2k citations indexed

About

N. Bellamy is a scholar working on Rheumatology, Surgery and Pharmacology. According to data from OpenAlex, N. Bellamy has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 10 papers in Surgery and 7 papers in Pharmacology. Recurrent topics in N. Bellamy's work include Osteoarthritis Treatment and Mechanisms (9 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Inflammatory mediators and NSAID effects (4 papers). N. Bellamy is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (9 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Inflammatory mediators and NSAID effects (4 papers). N. Bellamy collaborates with scholars based in United States, Canada and Australia. N. Bellamy's co-authors include David J. Watson, Beth C. Seidenberg, James A. Bolognese, Elliot Ehrich, Anthony Lembo, H. E. Gallo-Torres, Fermín Mearin, Lin Chang, Douglas A. Drossman and Peter J. Whorwell and has published in prestigious journals such as Cancer, CHEST Journal and Critical Care Medicine.

In The Last Decade

N. Bellamy

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Bellamy United States 14 514 445 340 166 146 42 1.2k
Elliott L. Semble United States 17 484 0.9× 381 0.9× 331 1.0× 65 0.4× 145 1.0× 30 1.2k
Harry Houben Netherlands 14 561 1.1× 129 0.3× 231 0.7× 27 0.2× 56 0.4× 16 1.1k
Augusto Zaninelli Italy 17 314 0.6× 255 0.6× 232 0.7× 42 0.3× 95 0.7× 61 1.1k
Nisha J. Manek United States 12 331 0.6× 332 0.7× 456 1.3× 11 0.1× 79 0.5× 20 1.2k
Lars Grøvle Norway 19 128 0.2× 277 0.6× 516 1.5× 15 0.1× 104 0.7× 45 1.0k
Rikke Helene Moe Norway 20 939 1.8× 362 0.8× 357 1.1× 9 0.1× 147 1.0× 49 1.8k
E. M. C. Lau Hong Kong 14 88 0.2× 205 0.5× 136 0.4× 76 0.5× 71 0.5× 17 769
Sibel Başaran Türkiye 15 137 0.3× 263 0.6× 109 0.3× 13 0.1× 195 1.3× 49 806
Devyani Misra United States 17 662 1.3× 990 2.2× 218 0.6× 10 0.1× 180 1.2× 34 1.8k
John Bedson United Kingdom 20 781 1.5× 537 1.2× 566 1.7× 6 0.0× 181 1.2× 34 1.6k

Countries citing papers authored by N. Bellamy

Since Specialization
Citations

This map shows the geographic impact of N. Bellamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Bellamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Bellamy more than expected).

Fields of papers citing papers by N. Bellamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Bellamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Bellamy. The network helps show where N. Bellamy may publish in the future.

Co-authorship network of co-authors of N. Bellamy

This figure shows the co-authorship network connecting the top 25 collaborators of N. Bellamy. A scholar is included among the top collaborators of N. Bellamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Bellamy. N. Bellamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellamy, N., et al.. (2020). 811: Fentanyl-Associated Serotonin Syndrome Five Days After Discontinuation of Fluoxetine: A Case Report. Critical Care Medicine. 49(1). 402–402.
2.
Aitken, Dawn, Laura L Laslett, Feng Pan, et al.. (2017). A RANDOMISED DOUBLE-BLIND PLACE-BOCONTROLLED CROSSOVER TRIAL OF ADALIMUMAB FOR EROSIVE HAND OSTEOARTHRITIS: THE HUMOR TRIAL. Osteoporosis International. 28. 1 indexed citations
3.
Fitzgerald, Timothy L., Jimmy T. Efird, N. Bellamy, et al.. (2017). Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients. Cancer. 123(15). 2909–2917. 25 indexed citations
4.
Phelps, Kevin D., et al.. (2016). A Quantitative Exposure Planning Tool for Surgical Approaches to the Sacroiliac Joint. Journal of Orthopaedic Trauma. 30(6). 319–324. 5 indexed citations
5.
Reginster, Jean‐Yves, R. Chapurlat, H K Genant, et al.. (2011). EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL. Osteoporosis International. 22. 1 indexed citations
6.
Drossman, Douglas A., Lin Chang, N. Bellamy, et al.. (2011). Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report. The American Journal of Gastroenterology. 106(10). 1749–1759. 172 indexed citations
7.
Botha-Scheepers, S., N. Riyazi, I. Watt, et al.. (2008). Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study. Annals of the Rheumatic Diseases. 68(8). 1260–1264. 73 indexed citations
8.
Greidanus, Nelson V., Jolanda Cibere, A. Thorne, et al.. (2008). RELIABILITY AND STANDARDIZATION OF THE HIP EXAMINATION IN OSTEOARTHRITIS. 131–131. 1 indexed citations
9.
Bellamy, N. & Chris Wilson. (2007). International estimation of Minimally Clinically Important Improvement (MCII75): The Reflect Study. Queensland's institutional digital repository (The University of Queensland). 37. 14 indexed citations
10.
Bellamy, N., J. A. Campbell, Travis Gee, et al.. (2005). Hylan G-F 20 (Synvisc) versus placebo: Cochrane Review 2005. Annals of the Rheumatic Diseases. 64. 492–492. 3 indexed citations
11.
Goldsmith, C. H., et al.. (2004). Abstracts. Osteoarthritis and Cartilage. 12. 1–148. 8 indexed citations
12.
Tubach, Florence, Gabriel Baron, Philippe Ravaud, et al.. (2003). Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis. Queensland's institutional digital repository (The University of Queensland). 48(9). 276–276. 5 indexed citations
13.
Bellamy, N.. (2003). Observations on alternate propositions for a short-form WOMAC osteoarthritis index (SF-WOMAC). Queensland's institutional digital repository (The University of Queensland). 62. 281–281. 1 indexed citations
14.
Bellamy, N., Sean Lybrand, & Thomas Gee. (2002). An evaluation of the convergence between three different methods of response status assignment (RSA) based on the WOMAC Osteoarthritis Index. University of Southern Queensland ePrints (University of Southern Queensland). 46. 2 indexed citations
15.
Lybrand, Sean & N. Bellamy. (2002). Impact of OARSI/OMERACT recommendations for outcome measurement on clinical practice: A 5 year reassessment. Internal Medicine Journal. 33(3). 112–112. 2 indexed citations
16.
Bellamy, N.. (2002). Outcome measures in osteoarthritis. Queensland's institutional digital repository (The University of Queensland). 129–129. 2 indexed citations
17.
Bellamy, N., et al.. (2000). A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.. PubMed. 27(6). 1506–12. 24 indexed citations
18.
Hunter, David, et al.. (1999). Corticosteroids, osteoporosis and the Australian rheumatologist. APLAR Journal of Rheumatology. 3(11). 326–330. 1 indexed citations
19.
Rosenbloom, David, E Grace, Peter Brooks, et al.. (1987). Effects of aspirin, naloxone and placebo. Clinical Rheumatology. 6(4). 526–531.
20.
Tugwell, Peter, Claire Bombardier, Kathryn Bennett, et al.. (1987). Low dose cyclosporine in rheumatoid arthritis: a pilot study.. PubMed. 14(6). 1108–14. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elliott L. Semble Breakdown of academic impact, for papers by Harry Houben Breakdown of academic impact, for papers by Augusto Zaninelli Breakdown of academic impact, for papers by Nisha J. Manek Breakdown of academic impact, for papers by Lars Grøvle Breakdown of academic impact, for papers by Rikke Helene Moe Breakdown of academic impact, for papers by E. M. C. Lau Breakdown of academic impact, for papers by Sibel Başaran Breakdown of academic impact, for papers by Devyani Misra Breakdown of academic impact, for papers by John Bedson
Rankless by CCL
2026